Rachit Khandelwal/X
Dec 25, 2024, 14:43
Rachit Khandelwal: P-I-M with CD19 CAR-T therapy linked to reduced survival in hematologic malignancies
Rachit Khandelwal, Pediatrics BMT fellow at Medanta The Medicity, Gurgaon, posted on X:
“Four weeks prior Exposure to broad-spectrum antibiotics Piptaz, imipenam, Meropenem (P-I-M) with CD19 CAR-T therapy is linked to reduced survival in hematologic malignancies.
Gut microbiome diversity plays a crucial role in CAR-T outcomes.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 1, 2025, 12:49
Feb 1, 2025, 12:21
Feb 1, 2025, 09:08
Feb 1, 2025, 09:02
Feb 1, 2025, 08:53